AMPH vs SUPN
As of Sep 20, 2026, Amphastar Pharmaceuticals (AMPH) scores 7.5/10 and Supernus Pharmaceuticals (SUPN) 2.7/10 on AlphaStocks' five-model composite, so AMPH scores higher. SUPN trades 38% above its model fair value.
AMPH
Amphastar Pharmaceuticals, Inc.
7.5
Strong Buy
$23.60
SUPN
SUPERNUS PHARMACEUTICALS, INC.
2.7
Avoid
$41.96
AMPH vs SUPN: Which is the Better Investment?
Amphastar Pharmaceuticals, Inc. (AMPH) scores 7.5/10 while SUPERNUS PHARMACEUTICALS, INC. (SUPN) scores 2.7/10 on AlphaStocks' composite model. Amphastar Pharmaceuticals, Inc. has the higher composite rating of Strong Buy.
This comparison is algorithmically generated and is not financial advice.
| Metric | AMPH | SUPN |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 7.5/10▲ | 2.7/10 |
| Rating | Strong Buy▲ | Avoid |
| Price | $23.60 | $41.96 |
| P/E Ratio | — | — |
| ROE | — | -3.7% |
| Market Cap | $1B | $2B |
| Fair Value | — | $30.30 |
| Dividend Yield | — | — |
| Sector Rank | #4 of 168▲ | #162 of 168 |
| Model Verdicts | ||
| Piotroski | Attractive▲ | Neutral |
| Buffett | Attractive▲ | Neutral |
| Graham | Attractive▲ | Caution |
| Lynch | Attractive | Attractive |
| Greenblatt | Attractive▲ | Caution |
Related comparisons
AMPH vs SUPN: Which Stock Scores Higher?
Amphastar Pharmaceuticals, Inc. (AMPH) and SUPERNUS PHARMACEUTICALS, INC. (SUPN) are both in the Health Care sector. AMPH currently leads with a composite score of 7.5/10 (Strong Buy) compared to SUPN's 2.7/10 (Avoid).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer